@storyeight92
Active 12 hours, 47 minutes ago
Increasingly, novel treatment approaches are being investigated in early phase clinical studies. Importantly, such therapies need to be evaluated in the context of both refractory and relapsed disease; in older patients and those with co-morbid conditions; and those with neurocognitive dysfunction. A deeper understanding of the molecular genetic […] View
Sorry, there was no activity found. Please try a different filter.